Capital Fund Management S.A. Cuts Stock Holdings in Cabot Corporation $CBT

Capital Fund Management S.A. lowered its position in shares of Cabot Corporation (NYSE:CBT) by 33.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,402 shares of the specialty chemicals company’s stock after selling 20,867 shares during the period. Capital Fund Management S.A. owned approximately 0.08% of Cabot worth $3,180,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CBT. Mackenzie Financial Corp raised its stake in shares of Cabot by 18.3% in the first quarter. Mackenzie Financial Corp now owns 7,840 shares of the specialty chemicals company’s stock worth $652,000 after purchasing an additional 1,210 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Cabot by 12.8% during the first quarter. PNC Financial Services Group Inc. now owns 4,356 shares of the specialty chemicals company’s stock valued at $362,000 after buying an additional 494 shares during the last quarter. New Age Alpha Advisors LLC increased its holdings in Cabot by 28.5% in the 1st quarter. New Age Alpha Advisors LLC now owns 3,480 shares of the specialty chemicals company’s stock worth $289,000 after buying an additional 771 shares in the last quarter. Ontario Teachers Pension Plan Board raised its position in Cabot by 180.8% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 60,712 shares of the specialty chemicals company’s stock worth $5,048,000 after buying an additional 39,089 shares during the last quarter. Finally, Citigroup Inc. lifted its stake in Cabot by 44.7% during the 1st quarter. Citigroup Inc. now owns 112,025 shares of the specialty chemicals company’s stock valued at $9,314,000 after acquiring an additional 34,582 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Price Performance

CBT opened at $64.01 on Wednesday. The firm has a market capitalization of $3.39 billion, a PE ratio of 10.65, a price-to-earnings-growth ratio of 3.30 and a beta of 0.90. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08. The business’s 50-day moving average is $67.52 and its two-hundred day moving average is $73.75. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $115.16.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a return on equity of 24.55% and a net margin of 8.91%.The firm had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. During the same period in the previous year, the firm earned $1.80 EPS. The firm’s quarterly revenue was down 10.2% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Investors of record on Friday, November 28th will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.8%. The ex-dividend date is Friday, November 28th. Cabot’s payout ratio is 29.95%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CBT. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Mizuho decreased their target price on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating for the company in a research note on Monday, November 17th. JPMorgan Chase & Co. lowered their price target on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. UBS Group cut their price objective on Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Cabot presently has a consensus rating of “Reduce” and a consensus target price of $63.67.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.